  
|
SEARCH:
Sponsored by:
|
 |  |  |  |  |  |  |  |
|
Cancer
|
|
|
ATLANTA – Men in their 40s with a low prostate specific antigen can probably safely delay additional testing for 10-15 years. Young men with a higher baseline level, however, are twice as likely to develop prostate cancer over the same time period and should probably have their PSA tested at... »
Concurrent Chemoradiotherapy Prolongs Survival for Elderly With NSCLC
Adding daily low-dose carboplatin chemotherapy to thoracic radiotherapy significantly extended survival in elderly patients with unresectable locally advanced non–small cell lung cancer, according to a study published online May 22 in the Lancet Oncology. Investigators from the Japan Clinical... »
U.S. Task Force Confirms Stance Against Universal PSA Screening
"Do not use prostate-specific antigen (PSA)–based screening for prostate cancer." With these words, the U.S. Preventive Services Task Force (USPSTF) finalized its stance against using this blood test to screen men universally in the United States for prostate cancer. This firm... »
Conferences
Gains in Melanoma Survival Attributed to Patient Awareness
WAIKOLOA, HAWAII – The improvement in melanoma survival over the past 4 decades can be attributed to effective public education campaigns, increased patient awareness, and improved physician skills and diagnostic tools,... »
Off-Label Use of Aprepitant Quells Refractory Pruritus
WAIKOLOA, HAWAII – Oral aprepitant has shown considerable promise as a novel therapy in patients with refractory pruritus, including those with severe itching induced by biologic therapies for cancer. "I think it’s a... »
Pregnant Women With Lymphoma Can Have Good Outcomes
SAN DIEGO – Women diagnosed with lymphoma during pregnancy stand a good chance of carrying a healthy child to term even when they opt for treatment during the second or third trimester, according to a retrospective... »
WAIKOLOA, HAWAII – The improvement in melanoma survival over the past 4 decades can be attributed to effective public education campaigns, increased patient awareness, and improved physician skills and diagnostic tools,... »
Off-Label Use of Aprepitant Quells Refractory Pruritus
WAIKOLOA, HAWAII – Oral aprepitant has shown considerable promise as a novel therapy in patients with refractory pruritus, including those with severe itching induced by biologic therapies for cancer. "I think it’s a... »
Pregnant Women With Lymphoma Can Have Good Outcomes
SAN DIEGO – Women diagnosed with lymphoma during pregnancy stand a good chance of carrying a healthy child to term even when they opt for treatment during the second or third trimester, according to a retrospective... »
News
PSA Level Could Determine Screening Frequency in 40s
ATLANTA – Men in their 40s with a low prostate specific antigen can probably safely delay additional testing for 10-15 years. Young men with a higher baseline level, however, are twice as likely to develop prostate cancer... »
Concurrent Chemoradiotherapy Prolongs Survival for Elderly With NSCLC
Adding daily low-dose carboplatin chemotherapy to thoracic radiotherapy significantly extended survival in elderly patients with unresectable locally advanced non–small cell lung cancer, according to a study published online... »
U.S. Task Force Confirms Stance Against Universal PSA Screening
"Do not use prostate-specific antigen (PSA)–based screening for prostate cancer." With these words, the U.S. Preventive Services Task Force (USPSTF) finalized its stance against using this blood test to screen... »
ATLANTA – Men in their 40s with a low prostate specific antigen can probably safely delay additional testing for 10-15 years. Young men with a higher baseline level, however, are twice as likely to develop prostate cancer... »
Concurrent Chemoradiotherapy Prolongs Survival for Elderly With NSCLC
Adding daily low-dose carboplatin chemotherapy to thoracic radiotherapy significantly extended survival in elderly patients with unresectable locally advanced non–small cell lung cancer, according to a study published online... »
U.S. Task Force Confirms Stance Against Universal PSA Screening
"Do not use prostate-specific antigen (PSA)–based screening for prostate cancer." With these words, the U.S. Preventive Services Task Force (USPSTF) finalized its stance against using this blood test to screen... »
Video Library
Evidence Suggests Pregnancies Can Survive Maternal Cancer Treatment
Emerging data on pregnancy and cancer can now help women and their doctors chart a safer course between effective treatment and protecting the developing fetus. Two registries – one in the United States and another in... »
BOLERO-2: Everolimus Plus Exemestane Delays Breast Cancer Progression
Combined treatment with everolimus and exemestane more than doubled median progression-free survival in postmenopausal women with hormone receptor–positive breast cancer that had advanced previously after hormone therapy.... »
Video Report: Genentech Defends Its Position on Avastin
On the second day of the Avastin hearing at the Food and Drug Administration, Genentech officials took the podium and in a two-hour session argued why Avastin should be approved for metastatic breast cancer. »
Emerging data on pregnancy and cancer can now help women and their doctors chart a safer course between effective treatment and protecting the developing fetus. Two registries – one in the United States and another in... »
BOLERO-2: Everolimus Plus Exemestane Delays Breast Cancer Progression
Combined treatment with everolimus and exemestane more than doubled median progression-free survival in postmenopausal women with hormone receptor–positive breast cancer that had advanced previously after hormone therapy.... »
Video Report: Genentech Defends Its Position on Avastin
On the second day of the Avastin hearing at the Food and Drug Administration, Genentech officials took the podium and in a two-hour session argued why Avastin should be approved for metastatic breast cancer. »
Views
Point/Counterpoint: Does Surgery Improve Survival in Stage IV Breast Cancer?
Yes – It Is Time to Consider a Paradigm Shift. In stage IV breast cancer, local therapy is not considered important except for controlling symptoms. But recent large-scale retrospective studies tell us that, if you follow... »
Perspective: Evaluating Genetic Risk for Breast Cancer
Approximately 12% of women will develop breast cancer over the course of their lifetimes with more than 200,000 expected to be newly diagnosed in 2010. Given the prevalence of breast cancer in the general population,... »
Yes – It Is Time to Consider a Paradigm Shift. In stage IV breast cancer, local therapy is not considered important except for controlling symptoms. But recent large-scale retrospective studies tell us that, if you follow... »
Perspective: Evaluating Genetic Risk for Breast Cancer
Approximately 12% of women will develop breast cancer over the course of their lifetimes with more than 200,000 expected to be newly diagnosed in 2010. Given the prevalence of breast cancer in the general population,... »
I would like to receive Family Practice News E-Newsletter each week.
Specialty Focus
Cancer Cardiovascular Disease Child & Adolescent Medicine Diabetes, Endocrinology & Metabolism Digestive Disorders Geriatric Medicine Kidney Diseases Men's Health Mental Health Musculoskeletal Disorders Neurologic Disorders Obesity Practice Trends Pulmonary & Sleep Disorders Skin Disorders Women's Health
Cardiovascular Disease RSS
Interested in being notified of new Cardiovascular Disease news?
Click here to view our Cardiovascular Disease RSS Feed.
calendar
More Calendar »
| May 18 - 23 San Francisco, CA | American Thoracic Society (ATS): International Conference |
| May 19 - 24 Atlanta, GA | American Urological Association (AUA): Annual Meeting |
| May 19 - 23 Stockholm, | European Calcified Tissue Society (ECTS): Annual Congress |
| May 20 - 23 Brisbane, | Australasian College of Dermatologists: Annual Scientific Meeting |
| May 20 - 23 San Antonio, TX | American Pediatric Surgical Association (APSA): Annual Meeting |
| May 20 - 23 Washington, DC | American College of Emergency Physicians (ACEP): Leadership & Advocacy Conference |
| May 21 - 23 Nice, | 12th International Review of Bipolar Disorders (IRBD 12) |
| May 21 - 25 Sarasota, FL | American Medical Seminars: Cardiology Update in Primary Care |
| May 22 - 25 Lisbon, | 21st European Stroke Conference |
| May 23 - 27 Philadelphia, PA | American Association of Clinical Endocrinologists (AACE): Annual Meeting and Clinical Congress |